Introduction
Benzene is a commonly used industrial solvent and a component of gasoline and mainstream cigarette smoke resulting in a significant potential for human exposure. Epidemiological studies have shown that chronic exposure to benzene increased the incidence of aplastic anaemia and acute myelogenous leukaemia in humans (Aksoy, 1985; Rinsky et al, 1987) . The occupational exposures of benzene associated with induction of aplastic anaemia and leukaemia in these studies are considered relatively high (30-650 p.p.m.) compared with present occupational exposure limits. The present Occupational Safety and Health Administration (OSHA) permissible exposure limit (PEL) for occupational exposure to benzene is 1 p.p.m., with a short-term exposure limit (STEL) of 5 p.p.m. averaged over 5 min (Feitshans, 1989) . This occupational exposure limit is presently based on the risk of leukaemia in humans, although the nature of the concentration-leukaemia response relationship at low exposure concentrations is not well understood. In addition, the mechanism of benzene-induced leukemogenesis is not known. Several proposed mechanisms are in the literature, including the hypothesis that benzene or benzene metabolites cause mutations in haematopoietic cells that can initiate leukaemia (Paustenbach et al, 1993) .
Several studies have shown benzene to be clastogenic by evaluating the frequency of micronucleated erythrocytic cells following in vivo exposure of rodents to high concentrations of benzene (Diaz et al, 1979; Hite et al, 1980; Erexson et al., 1986; Ciranni et al, 1988; Luke et al, 1988a; Sabourin et al, 1990) . A micronucleus is residual DNA in an erythrocyte that indicates chromosome breakage and separation of the whole or partial chromosome from the nucleus during a division before extrusion of the erythrocyte nucleus in the later stages of erythrocyte maturation. Micronuclei can be evaluated in maturing erythrocytes that have just extruded the nucleus but retain some cytoplasmic RNA, polychromatic erythrocytes (PCE), of the bone marrow or blood and in mature erythrocytes, normochromatic erythrocytes (NCE), of the blood. The PCE stage lasts ~24 h during which time the RNA will gradually decrease within the cell due to the loss of mitochondria and ribosomes. When the RNA is minimal, the cell is then termed a NCE. NCE have a life span of ~30 days in the blood. If a micronucleus is present, this DNA material is not later extruded by the NCE like the nucleus was.
In benzene-induced micronucleated erythrocyte studies to date, the evaluation and counting of cells has been by fluorescent or bright field light microscopy. Acridine Orange is a dye that fluoresces differentially when bound to RNA and DNA, providing clear distinction of maturation stages of the erythrccytes and presence of micronuclei. Evaluating bone marrow slides stained with Acridine Orange can be difficult if the slide preparation has a crowding of cells. The discrimination of PCE from NCE, and micronuclei from artefact, is not always as clear when polychromatic stains, such as Giemsa, and light microscopy are used. Since the loss of RNA from an erythrocyte during maturation is a gradual process, the threshold of polychromatic staining intensity for counting a cell as a PCE for each stained slide is inherently subjective. For each blood or bone marrow analysis, 1000 or 2000 cells are evaluated depending on the investigator's preference. Often multiple smears are required to evaluate at most 500 PCEs if there is a decrease in erythropoiesis. The evaluation of blood and bone marrow smears for micronucleated erythrocytes by fluorescent or light microscopy is labour intensive. Studies to examine the clastogenicity of benzene in rodents have been limited to single sampling times, small numbers of rodents per treatment group, and in most studies only one benzene concentration.
The development of flow cytometric techniques to assay for the presence of micronucleated PCE (MPCE) and micronucleated NCE (MNCE) of the blood and bone marrow (Graw6 et al, 1993) provided a method of analysing a large number of cells with objectively-defined classifications. Bias toward noticing cells with fluorescence or staining and observer fatigue, that are of concern with microscopic evaluation, are not factors in the analysis of the samples by flow cytometry. The sensitivity and relative automation of this assay allow rapid evaluation of micronucleated erythrocytes in a large number of samples allowing the design of studies using several exposure concentrations and several durations of exposure.
The objective of the present study was to determine if 1 or 10 p.p.m. benzene induced an increase in the frequency of micronucleated erythrocytes in mice and comparison with the responses measured with 100 and 200 p.p.m. The frequencies of micronucleated erythrocytes were evaluated during an 8 week period to determine the exposure period required for maximum frequencies at each concentration and to examine the impact of erythropoietic cytotoxicity. The fit of linear and quadratic regression models with the data was examined. This study used a strain and sex of rodent, male B6C3F1 mice, with high sensitivity to benzene mutagenicity (Luke et al., 1988a,b) , and the exposure regime was similar to an occupational exposure, 6 h/day and 5 days/week.
Materials and methods

Animals
This study was conducted under federal guidelines for the use and care of laboratory animals (National Institutes of Health. 1985) Male B6C3FI/CrlBR mice were obtained from the Charles River Breeding Laboratories, Inc. (Portage, MI, USA) Mice were 12 weeks ± 2 days of age on the first day of exposure Mice were housed one per cage in 8 m' stainless steel and glass inhalation chambers Separate chambers were used for each exposure concentration. NIH-07 rodent chow (Ziegler Bros., Gardener, PA. USA) and deionized, filtered tap water were available ad libitum throughout the acclimation and exposure periods. Mice were acclimated to these conditions for 10-17 days. The food was changed daily, immediately following the end of each exposure period. Animals were randomized by weight in treatment groups. There were seven mice in each exposure group at each necropsy date for a total of 28 mice in each exposure chamber for micronucleus analysis and a total of 140 mice for this study.
Generation and characterization of atmospheres
High purity liquid chromatography grade (>99.9% punty) ben/.ene was purchased from VWR Scientific (Marietta, GA, USA). The purity was verified using gas chromatography. Benzene exposures were conducted in 8 m 1 stainless steel and glass Hinners-style whole body inhalation chambers The exposures (generation and monitoring) were fully automated (Wong and Moss. 1996) . Air was conditioned to 72°F and 50* humidity and maintained at a flow of 2000 l/min through the chambers The environmental parameters of temperature, relative humidity, airflow and static pressure were continuously monitored.
Exposures were conducted 5 days/week with a total exposure time of 6 h/ day. The concentration atmospheres of 10. 100 and 200 ppm ben/.ene were generated by vaporizing liquid benzene contained in a 10-gallon stainless steel pressure vessel. A controlled flow of nitrogen was bubbled through the liquid benzene and earned vapours out of the vessel into the chamber air inlet. The 1 p.p.m. benzene atmosphere was also generated from a pool of liquid benzene, however, the pressure vessel was maintained at 10 p.s.i. gauge pressure with nitrogen. The flow of the benzene vapours and nitrogen into the chambers was controlled by mass flow controllers placed on the outlet side of the pressure vessels.
An infrared (IR) gas analyser (Miran I A. The Foxboro Co.. South Norwalk. CT, USA) at a wavelength of 9 9 |im was used to monitor the 0. 10. 100 and 200 p.p.m. benzene concentrations The I p.p.m chamber was monitored by gas chromatography (model 5890 Series II. Hewlett Packard Co.. Palo Alto. CA, USA) using a column (AT-I 15X0.53 mm. Alltech, Deerfield. IL, USA) with helium as the carrier gas and a flame lonization detector. Monitors were calibrated with certified gas standards at I and 10 p.p.m. (Matheson Gas Products. Atlanta. GA. USA) and with a standard closed-loop technique for the 100 and 200 p.p.m. concentrations. The analytical concentrations of benzene within the individual chambers were stable during each exposure period and over the time course of the studies The actual concentrations of benzene averaged (± SD) 0.95 -0 09. 9.9 z 1.2. 98.5 z 1.5 and 198.5 z 4 8 p p.m.
Blood and bone marrow collection and erythrocxte counts
Mice scheduled for killing and dissection were removed from the chambers and blood and bone marrow were collected within 2 h after the end of the exposure. Mice were anaesthetized by inhalation of COi and killed by exsanguination when blood was drawn from the heart and then transferred to a tube containing EDTA The right femur was removed and the bone marrow was flushed with 2 ml of Hanks balanced salt solution (Gibco BRL. Gaithersburg, MD, USA) with 5* horse serum (Sigma, St Louis. MO. USA) into a collecting tube Total bone marrow cells and nucleated cell counts were determined using an electronic particle counter (Coulter Counter Model ZM. Coulter Electronics Ltd.. Beds. UK). Nucleated cell counts, requiring the addition of erythrocyte lysing agent, were subtracted from total cell counts to calculate the bone marrow erythrocyte count Blood samples were evaluated for erythrocyte counts per {aI blood using a MASCOT CE haematology analyser (CDC Technologies. Oxford. CT. USA) which was calibrated for mouse blood.
Erythrocxle fixation ami staining for flow tvlometric analysis
The fixation and fluorochrome staining followed a previously described method (Grawe et al. 1992 ) with a few modifications in sample preparation Briefly, within 30 min of blood collection, 3 Hi of blood was added directly to 2 ml of a freshly made mixture of \% gluteraldehyde (5(>% EM grade. Ted Pella. Inc . Tustm. CA. USA) and 30 ng/ml sodium dodecyl sulphate (SDS) (Sigma) in phosphate-buffered saline (PBS) Within 30 mm of marrow collection. 300 \l\ of the bone marrow cell suspension was added directly to 1.5 ml of fixative composed of 1.3% gluteraldehyde and 45 (ig/ml SDS in PBS Cells in fixative were mixed well and stored overnight at 4°C. The next morning, the fixative was aspirated and 1 ml of PBS was added to wash the cells The samples were centnfuged (600 g. 5 min) and the PBS aspirated Two ml of fluorochrome stain solution was then added to each tube Fluorochrome stain solution was composed of 1 ml of Hoechst 33342 stock (HO342: Sigma. 250 |jg/ml in distilled water) and 50 \i\ of Thiazole Orange stock (TO: I mg/ml in methanol. Aldnch, St Louis, MO. USA) in 100 ml of PBS The samples were gently mined and kept in the dark at 37°C for 45 mm Samples were kept in the dark at room temperature until acquisition of data on the flow cvtometer which occurred within 2 h of sample preparation.
Flow cvtometnc data acquisition
The samples were analysed using a flow cytometnc method for detection of micronuclei (Grawe et al.. 1992) . The flow cytometer (FACSVantage. Becton-Dickinson. San Jose. CA, USA) was equipped with a laser capable of simultaneous output of UV (351-364 nm) at 55 mW and visible blue (488 nm) at 278-302 mW (Enterprise, Coherent. Palo Alto. CA. USA) The Forward Scatter (FSC) signals were collected on a linear scale, while the Side Scatter (SSC), TO and HO342 signals were collected on a 4 decade log scale A gate was set on the dot plot of FSC and SSC to include all erythrocytes and polychromatic erythrocytes and to exclude most nucleated cells Instrument settings were not altered during acquisition of FSC, SSC, TO fluorescence and HO342 fluorescence of blood and bone marrow samples for all treatment groups. From each blood and bone marrow sample. 50 000 events from this gate were collected. The acquisition rate was 2000-3000 erythrocytes/s If the number of PCE in the bone marrow sample was <5000 out of the total events collected (50 000) this indicated an error in sample preparation and the data was not included in the analysis Once the data was acquired from each sample the information was saved in a file specific for that sample and was analysed at a later date for calculation of frequencies of micronuleated erythrocytes
Calculation of PCE. MPCE and MNCE frequencies
Sorting of PCE. NCE, MPCE and MNCE populations, and then examination of these cells by fluorescent microscopy, verified that the gating was appropriate to separate and quantify these populations For each experiment, dot plots representing DNA content (HO342 intensity) versus RNA content (TO intensity) in blood and bone marrow of control mice were used to determine the cut-off region for PCEs from the NCE population. Figure 1 shous representative dot plots for bone marrow (Figure la ) and blood ( Figure 1b ) from control samples and illustrates the separation of the NCE. PCE. MNCE and MPCE population into four regions. The MPCE and MNCE regions were similar to those in a previous description (Grawe el al.. 1992) Once the four regions were set for blood at each sample time, samples from all treatment groups were analysed without alteration of regions Slight shifting in the intensity of fluorescence in individual bone marrow samples made it necessary to slightly shift the set of four regions for analysis without changing the shapes or sizes of the regions or the association of the regions to each other. For accurate analysis of bone marrow samples, the data files were assigned a randomized code. By randomizing and coding the files, the person analysing the data from the bone marrow samples did not know the concentration of benzene that each mouse was exposed to Therefore, if a change in staining intensity required a slight shift in the set of regions, operator bias wa,x eliminated
The frequency of micronucleated erythrocytes was calculated by dividing the number of micronucleated cells within a region by the total number of cells within the population of erythrocytes (PCE + MPCE or NCE + MNCE) for each acquisition. This frequency was then reported as number per 1000 as traditionally reported in the literature. The frequency of PCEs in the blood was calculated by dividing the number of cells in the PCE region by the total number of erythrocytes for each acquisition. This frequency was then multiplied by the number of erythrocytes per \x] blood to calculate the number of PCE per |il blood.
Sorting MPCE of bone marrow
Bone marrow cells without nuclei that had positive TO staining and positive HO staining were sorted for identification of the erythrocyte maturation stage and presence of micronuclei. Two randomly-chosen mice from each treatment group at the 8 week sample time, had 200 cells from the MPCE region of the TO-HO dotplot (shown in Figure la ) sorted onto a microscopic slide. The flow cytometer allows non-rectangular gating, so the MPCE region was the same as used in analysis. The slide was then evaluated by fluorescent microscopy for TO and HO fluorescence and the cells identified for maturation stage and presence of micronuclei.
Manual counting of bone marrow MPCE
Bone marrow cells from the I week exposure mice were adjusted to 1X10 6 / ml, then two cytospin preparations were made with 300 nl samples for each mouse. These cytospin preparations were air dried and then fixed in absolute methanol at 25°C for 10 min. The slides were then air dried and stored at room temperature. The slides were coded with a randomized number before analysis to blind the observer to the treatment group that each bone marrow sample was from. The slides were stained with Acridine Orange (0.06 mg/ml [0.24 m.M] in pH 7.4 PBS) for 3 min and then washed for 9 min. Coverslips were floated onto the wet slides. Slides were analysed under oil immersion, at XI GOO, using fluorescence microscopy (450-490 nm excitation, 520 nm emission) for the number of MPCE per 1000 PCE counted. Acridine Orange-stained PCE had an orange cytoplasm due to the presence of RNA while the NCE stain only a very pale green. If a micronucleus was present the DNA material was bright yellow. Out of the total of 35 bone marrows examined, only three samples had an insufficient number of PCE on the cytospins making a scoring of 1000 PCE impossible. The PCE count from these samples (one each from 0, 10 and 100 p.p.m. groups) was 580-780 and was adjusted to the frequency of MPCE per 1000 PCE.
Statistics
The frequency of MPCE in bone marrow and MPCE, MNCE, percentage PCE and erythrocyte counts in blood were determined for individual mice. The large number of erythrocytes examined for each sample provided a very precise estimate of the frequency of micronucleated erythrocytes for each animal. The precision of the measurement for each sample was so great that, even though the control mice have a normal distribution of frequencies, using the raw numbers in analyses leads to rejection of homogeneity. For each timepoint, the data from each benzene exposure group was compared to the controls using Dunnett's analysis of variance (ANOVA) with a 5<i significance level. Linear [y = bo + b|X] and quadratic [y = bo -*• b,x + t>2X 2 ] regression models were fit to the bone marrow MPCE data. Evaluation of linear and quadratic curves with the data required a weighted analysis (weight = 1/ estimated variance) because of nonhomogeneous variability. A P value of <0.05 for lack of fit test meant that the curve was not appropriate for the data set.
Results
Benzene treatment caused a statistically significant increased frequency of MPCE in the bone marrow of mice at the 100 and 200 p.p.m. concentrations at all four timepoints. Figure  2a shows a representative dot plot of the NCE, PCE and MPCE of the bone marrow for a mouse exposed to 200 p.p.m. benzene for 4 weeks. After 1 week, the frequency of MPCE in the bone marrow of mice exposed to 100 and 200 p.p.m. benzene was 33 and 70/1000 respectively, in comparison with 10/1000 in the controls (Table I and Figure 3 ). The frequency of bone marrow MPCE induced by 100 and 200 p.p.m. benzene increased to, and plateaued at, 43/1000 and 86/1000 by week 2 respectively, compared with a control frequency of 10/1000. Exposure to 1 or 10 p.p.m. did not induce a statistically significant change in the frequency of MPCE compared with controls. Table I Although weighted linear and quadratic concentrationresponse curves were statistically significant and had very high R 2 values (Table II) , the linear model was rejected by the lack of fit test, while the quadratic model could not be rejected. Figure 4 shows the quadratic curve with the concentrationresponse frequencies of bone marrow MPCE at the 8 week timepoint. The linear parameter of the quadratic equation, b|X, did not have a major impact on the quadratic curve (P = 0.325) and by removing this parameter [giving the model y = b (1 + b 2 x 2 ], the curve fits the bone marrow MPCE data at the 8 week timepoint very well (R 2 = 0.934, lack of fit P = 0.120). In addition, a quadratic curve fits the 8 week bone marrow MPCE data up to 100 p.p.m. and a linear curve is again rejected based on lack of fit (P = 0.008).
The average number of bone marrow PCE + MPCE evaluated in samples from the 0, 1, 10 and 100 p.p.m. benzene exposure groups was 13 000-23 000 of the total 50 000 events acquired. The number of bone marrow PCE + MPCE evaluated from the 200 p.p.m. groups was 17 000 in samples at week 1 and 11 000-12 000 at weeks 2, 4 and 8. Data from three bone marrow samples were discarded because of inadequate sample preparation, including one each from the 0, 1 and 100 p.p.m. treatment groups.
Sorting the cells from the MPCE region in the bone marrow samples from mice in each treatment group at the 8 week sampling time allowed identification of the cells in this region. Evaluation of the cells sorted determined that about six to eight PCE without micronuclei per 1000 PCE in the bone marrow are located in the MPCE region of mice from each of the treatment groups. This low frequency composes a larger percentage of the total MPCEs in the region of control mice than for mice exposed to high concentrations of a clastogenic toxin and is similar to the purity described by Grawe et al. (1993) .
The frequencies of MPCE evaluated by manual counting of bone marrow cytospins from mice exposed to benzene for 1 week, were similar to the concentration response demonstrated by flow cytometry. Only 100 and 200 p.p.m. benzene induced a statistically significant increased frequency of MPCE at 20.4 ± 6.8 and 57.1 ± 9.8/1000 PCE respectively, in comparison with the control frequency of 4.6 ± 2.4/1000. The effects of 1 and 10 p.p.m. were not statistically significant from control at 3.6 ± 3.5 and 3.1 ± 1.2/1000 respectively. Figure 5 demonstrates the similarity of the concentration response when each method of evaluating micronuclei (AO and TO-HO) were used on the same 35 bone marrow samples.
The 100 and 200 p.p.m. benzene concentrations induced a statistically significant increase in frequency of MNCE in the blood (Table III and Figure 6 ). The frequency of MNCE in the blood of mice exposed to 100 p.p.m. benzene was significantly increased by 1 week to 2.9/1000 when compared with controls of 1.67/1000, and reached a plateau by 4 weeks of 10/1000 with a similar frequency at week 8 of 13.4/1000. Mice exposed to 200 p.p.m. benzene also had a significantly increased frequency of MNCE of 2.6/1000 by 1 week, but in contrast with the 100 p.p.m. treatment group, mice exposed to 200 p.p.m. continued to have a progressive increase in the frequency of blood MNCE through week 8 reaching 32.5/1000. Data from an additional timepoint after 8 weeks would be needed to determine if 32.5/1000 was the maximum frequency of MNCE in the blood induced by 200 p.p.m. benzene. The 1 or 10 p.p.m. exposures did not cause a statistically significant change in the frequencies of MNCE in the blood. The average number of NCE + MNCE evaluated in the blood was 38 000-46 000 of the total 50 000 events acquired for all exposure concentrations. Blood cell counts had a significant decrease in the number of erythrocytes per (il of blood by 1 week after exposure to (Table IV) . Exposure to 1 or 10 p.p.m. benzene did not induce a statistically significant change in blood erythrocyte counts.
The number of PCE per (il blood (Table IV) and percentage PCE in blood (data not shown) were significantly decreased after 1 week of exposure to 100 or 200 p.p.m. and continued to be lower than controls through week 4 with 200 p.p.m.. The number of PCE in the blood of mice exposed to 100 or 200 p.p.m. benzene were close to the count in control mice, 0.25 X ltfVuJ, at week £ The production of PCEs in the bone marrow could not be accurately measured because the benzeneinduced cytotoxicity caused an accumulation of mature erythrocytes in the bone marrow and this distorted and invalidated the bone marrow PCE to NCE ratio. The absolute number of erythrocytes in the bone marrow of control mice was ~30X 10 6 per femur. In the 200 p.p.m. benzene-treated mice, the femur erythrocytes increased from 44X lC^/femur at day 5 to 73X10 6 / femur at week 8. Histological sections demonstrated erythrocytes in the space left by the loss of haematopoietic cells.
Discussion
Flow cytometric assessment of NCE, PCE, MPCE of the bone marrow and MNCE of the blood allowed accurate and efficient measurement of changes in the frequency of micronuclei induction as a function of benzene inhalation with respect to both concentration and time. Inhalation of 1 or 10 p.p.m. benzene by male B6C3F1 mice did not cause a statistically significant increased frequency of MPCE of the bone marrow or MNCE of the blood over an 8 week study, compared with air controls. In contrast, 100 and 200 p.p.m. benzene induced a dramatic and concentration-dependent increase in the frequency of MPCE and MNCE in the mice. A quadratic curve fit the frequencies of MPCE at concentrations =s200 p.p.m. benzene. A linear curve was not appropriate based on lack of fit of the multiple data points for each concentration response with the curve. The frequency of bone marrow MPCE in mice with 100 or 200 p.p.m. benzene continued increasing between weeks 1 and 2 due, in part, to time required for early progenitor cells with micronuclei to mature to reticulocytes and in part altered by cytotoxicity of benzene to the replicating and maturing eythropoietic cells. The decreased number of PCE in the blood of mice exposed to 100 or 200 p.p.m. benzene reflects the cytotoxicity of benzene to cells within the erythrocyte lineage. Investigations of benzene-induced haematotoxicity at our laboratory using monoclonal antibodies to label replicating and differentiating erythrocytes demonstrated a dramatic reduction in the absolute number of femoral erythropoietic cells after 5 benzene did not induce a statistically significant change in frequency of MNCE in comparison with the mice exposed to 0 p.p.m.. the data are included in Table III days of exposure to 100 or 200 p.p.m. benzene to 65 and 60% of the control respectively (Farris et al, unpublished The frequency of MPCE in the bone marrow of mice exposed to 100 or 200 p.p.m. benzene remained stable during week 2 through week 8, suggesting exposure of the bone marrow cells to a similar amount of benzene, or mutagenic benzene-metabolites, over the 8 week period. There did not appear to be a development of protection or tolerance by the erythropoietic cells to the mutagenic toxin. In contrast, several parameters of haematopoietic cell toxicity induced by 100 p.p.m. benzene returned toward control values by week 8, possibly by the development of tolerance or compensation by the target populations (Farris et al, unpublished) .
It is important to note that extrapolation of benzene-induced mutations in mice to the probable response in humans includes recognition of species differences in the target tissue dose of benzene metabolites with the same exposure concentration. Previous modelling by Seaton et al. (1995) of benzene kinetics using metabolite data from mouse and human liver microsome studies, predicted the steady-state concentrations of phenol and hydroquinone in mice were higher than predictions for the 10 human subjects with a continuous exposure to benzene (0.01 |iM in blood) (Seaton et al., 1995) .
High concentrations of benzene (300-1000 p.p.m.) induce micronuclei in PCE and NCE of mice and rats via inhalation (Erexson et al., 1986; Luke et al., 1988a; Sabourin et al., 1990) , oral (Hite et al., 1980; Ciranni et al. ,1988) or parenteral routes of exposure (Diaz et al., 1979) . Results from studies using high concentrations of benzene delivered by inhalation to induce an increased frequency micronucleated erythrocytes have not been consistent. Sabourin et al. exposed male B6C3F1 mice to 600 p.p.m. benzene by nose-only inhalation for 6 h/ day, 5 days/week for 4, 11 or 20 days and reported only a mild increase in MPCE in the blood at 5.7, 6.83 and 6.9/1000 respectively, when compared with 2.2/1000 for controls. The increased frequency of blood MNCE was slightly increased at only the 20 day timepoint with 3.77/1000 in comparison with 2.08/1000 for controls. The blood smears were stained with Hoechst 33258/pyronin Y fluorescent staining and evaluated by fluorescent microscopy. Surprisingly, the percentage PCE in the blood did not decrease with exposures to 600 p.p.m. in this experiment by Sabourin et al. Luke et al. (1988b) demonstrated an increase in MPCE in the blood of male DBA/2 mice exposed to 300 p.p.m. benzene for 13 weeks with a temporal average of 107.85/1000 when compared with 2.05/1000 for controls. Similarly, the MNCE in blood was increased to 23.47/1000 in comparison with 1.70/1000 for controls. Luke et al. assessed micronucleated erythrocytes by examination of Acridine Orange-stained blood smears using a fluorescent microscope. They reported a dramatic benzene-induced reduction in the percentage of PCE in the blood. The results of the present study were consistent with the results of Luke et al. (1988b) after exposure of mice to high concentrations of benzene. The frequency of 96/1000 bone marrow MPCE in mice exposed to 8 weeks of 200 p.p.m. benzene was similar to the 107/1000 blood MPCE demonstrated by Luke et al. (1988b) in mice exposed to 13 weeks of 300 p.p.m.
One study (Erexson et al, 1986 ) demonstrated an increased frequency of micronucleated erythrocytes after exposure of mice to a low concentration of benzene. Male, DBA/2 mice, 17-19 week old were exposed to a single 6 h nose-only inhalation of 10, 100 or 1000 p.p.m. benzene in groups of five mice per concentration. Bone marrow samples were collected 18 h later and bone marrow smears were stained with May-Grunwald and Giemsa stains for evaluation of MPCE. In the Erexson et al. study, 10, 100 and 1000 p.p.m. induced an increased frequency of MPCE in the bone marrow at 9.0, 20.3 and 28.1/1000 respectively, in comparison with a control value of 2.1/1000.
The present study demonstrated no increased frequency of micronucleated erythrocytes after exposure to 10 p.p.m. benzene, unlike results obtained by Erexson et al.. Erexson et al. exposed DBA/2 mice to a single 6 h exposure whereas the present study evaluates the results of repetitive exposures to B6C3F1 mice after a minimum of 5 days. Without further investigation of the effects of 1, 2 and 3 day exposures of mice to 10 p.p.m. benzene, explaining why the present study and the Erexson study had very different results would be speculation.
This automated method for evaluating micronucleated erythrocytes by flow cytometry was sensitive for analysis of the frequency of MPCE and MNCE in mice exposed to low concentrations of benzene. Features of the flow cytometry method and the study design that ensured precise measurement of MPCE and MNCE included, an objective determination of erythrocyte maturation stage and presence of micronuclei, evaluation of a large number of cells per sample, and MNCE levels were allowed to reach a maximum during the 8 week period. In addition, the frequency of MPCE in bone marrow of benzene-treated mice measured by the flow cytometry method correlated very well with the frequency measured using a manual method.
The detection by flow cytometry of PCE with DNA staining in the bone marrow which do not contain a micronucleus detectable by fluorescent microscopy is a factor for consideration when incorporating this flow cytometry method into a study. The flow cytometer may be detecting micronuclei that are extremely small and are not identified by the eye using fluorescent microscopy, or residual microsomal DNA in very early reticulocytes may be binding Hoechst 33342. Identification of this consistent and very small population of cells within the Hoechst positive region of the dot plot may lead to development of methods to account for these cells in the analysis. Until these cells are characterized, frequencies of micronucleated erythrocytes determined by flow cytometry should be compared with those from manual counting, especially if weak mutagenic toxins or low doses are tested. In addition, MNCE in the blood should be evaluated after an adequate accumulation period for determination of an accurate concentration response.
The present study evaluated the frequency of micronucleated erythrocytes in mice in a concentration response over an 8 week exposure period. There was a statistically significant increase in MPCE and MNCE induced by 100 and 200 p.p.m. benzene with a concentration-related effect. Inhalation of 1 or 10 p.p.m. benzene by male B6C3F1 mice did not induce a statistically significant increase in the frequency of MNCE of the blood or MPCE of the bone marrow during an 8 week exposure study that mimicked an occupational exposure regime, i.e. 1 p.p.m. benzene. A quadratic concentrationresponse curve fit to frequency MPCE data from bone marrow of mice exposed to =S200 p.p.m. benzene had a high correlation (R 2 = 0.94) and could not be rejected based on lack of fit.
